Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» epilepsy
epilepsy
UCB backs epilepsy-focused digital heath startup Nile AI
Pharmaforum
Fri, 01/15/21 - 10:02 am
UCB Pharma
digital health
Nile AI
artificial intelligence
epilepsy
In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate
Endpoints
Mon, 01/4/21 - 10:41 am
Arvelle Therapeutics
Angelini Pharma
M&A
CNS
epilepsy
cenobamate
Axovant
Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy
Pharmaceutical Business Review
Wed, 11/18/20 - 11:59 am
Cerebral Therapeutics
clinical trials
CT-010
epilepsy
France’s Medicine Watchdog Indicted Over Sanofi’s Birth Defect-Causing Drug
BioSpace
Sat, 11/14/20 - 02:00 pm
Sanofi
Depakine
France
epilepsy
Ovid shows mixed results on epilepsy program
Endpoints
Wed, 09/30/20 - 10:49 pm
Ovid Therapeutics
clinical trials
epilepsy
Epilepsy gene therapy candidate moves closer to clinical study phase
Biopharma Reporter
Thu, 09/17/20 - 10:46 am
CombiGene
Cobra Biologics
CDMOs
gene therapy
epilepsy
CG01
Sanofi faces manslaughter charges in France over yearslong Depakine probe
Fierce Pharma
Mon, 08/3/20 - 11:27 pm
Sanofi
France
Depakine
birth defects
epilepsy
FDA Approves Zogenix's Drug for Rare Childhood Epilepsy
NY Times, NY
Fri, 06/26/20 - 09:46 am
FDA
Zogenix
epilepsy
Dravet syndrome
UCB buys epilepsy firm Engage Tx in $270m deal
PM Live
Mon, 06/8/20 - 10:30 am
UCB Pharma
epilepsy
M&A
Engage Therapeutics
drug-device combos
Staccato Alprazolam
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
Xconomy
Mon, 05/4/20 - 10:34 pm
Praxis Precision Medicines
epilepsy
R&D
Redpin Launches with $15.5 Million Series A to Focus on Pain and Epilepsy
BioSpace
Wed, 03/25/20 - 10:38 am
Redpin Therapeutics
chronic pain
epilepsy
FDA pushes back decision on Zogenix epilepsy drug
BioPharma Dive
Thu, 02/27/20 - 11:41 pm
Zogenix
epilepsy
Fintepla
FDA
Dravet syndrome
Zogenix's Positive Clinical Trial Wasn't Positive Enough
Motley Fool
Sun, 02/9/20 - 04:08 pm
Zogenix
epilepsy
Lennox-Gastaut Syndrome
clinical trials
Fintepla
GW Pharma
Epidiolex
Sanofi investigated over epilepsy drug linked to birth defects
Reuters
Tue, 02/4/20 - 10:20 am
Sanofi
epilepsy
birth defects
Depakine
Neurocrine signs $400M-plus deal with Idorsia for epilepsy drug
Pharmaforum
Fri, 01/10/20 - 10:23 am
Idorsia
Neurocrine Biosciences
epilepsy
pediatric epilepsy
ACT-709478
SK Biopharmaceuticals IPO Tabbed to Raise $850 Million
Yahoo/Guru Focus
Tue, 12/3/19 - 10:20 am
SK Biopharmaceuticals
IPOs
South Korea
epilepsy
Xcopri
Digital Health Trial Uses AI For Better Epilepsy Treatment Decisions
Forbes
Tue, 12/3/19 - 12:05 am
epilepsy
clinical trials
artificial intelligence
digital health
Neurocrine is beefing up its pipeline, splurging $50M on rights to an epilepsy drug
Endpoints
Mon, 12/2/19 - 10:35 am
Neurocrine
epilepsy
Xenon
XEN901
Cadence Raises $15M in a Healthy and Growing Neuromodulation Market
Medical Devices and Diagnostics Industry
Wed, 11/6/19 - 05:23 pm
Cadence Neuroscience
neuromodulation
epilepsy
devices
New Data Could Boost Potential Approval of Zogenix's Epilepsy Drug
BioSpace
Fri, 10/25/19 - 10:42 pm
Zogenix
Fintepla
Dravet syndrome
epilepsy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »